Back

A comparison of leadless and conventional transvenous pacemakers in elderly patients: short-term outcomes systematic review and meta-analysis

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Leadless pacing (2) Antibradycardia Pacing EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Alfredo Aurelio Marinho Rosa Filho

Dante Pazzanese Institute of Cardiology, Sao Paulo (Brazil)

5 More presentations in this session

Presentation thumbnail
Long-term atrioventricular-synchronous leadless pacing with micra AV: stable AV synchrony up to 4 years follow-up
Doctor S. Briongos Figuero (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Are contemporary leadless pacemakers resistant to smartphone-induced magnetic interference? A preclinical evaluation.
Doctor M. Dyrbus (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Jugular approach for implantation of helix-based leadless pacemakers: first clinical experience in 30 patients
Ms L. Esser (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Predictors of long-term atrioventricular synchrony with leadless Micra AV pacemaker: insights from a real-world cohort
Assistant Professor C. Garweg (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: final results from the Micra AV Post-Approval Registry
Doctor C. Garweg (Leuven, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Leadless pacing (2)

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Leadless vs. transvenous pacemaker strategy following transcatheter aortic valve replacement: a systematic review and meta-analysis
thumbnail
Congress Presentation
Comparative efficacy and safety of lead-less pacemakers in patients requiring cardiac devices: meta-analysis
thumbnail
Congress Presentation
Systematic review of the outcomes and complications of the leadless pacemaker placement based on the national level data

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources